These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21900081)

  • 1. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload.
    Carnevale D; Cifelli G; Mascio G; Madonna M; Sbroggiò M; Perrino C; Persico MG; Frati G; Lembo G
    Circulation; 2011 Sep; 124(12):1337-50. PubMed ID: 21900081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
    Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
    Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
    Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.
    Javan H; Szucsik AM; Li L; Schaaf CL; Salama ME; Selzman CH
    Circ Heart Fail; 2015 Jan; 8(1):109-18. PubMed ID: 25480781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP-3 deficiency leads to dilated cardiomyopathy.
    Fedak PW; Smookler DS; Kassiri Z; Ohno N; Leco KJ; Verma S; Mickle DA; Watson KL; Hojilla CV; Cruz W; Weisel RD; Li RK; Khokha R
    Circulation; 2004 Oct; 110(16):2401-9. PubMed ID: 15262835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of copper and homocysteine in pressure overload heart failure.
    Hughes WM; Rodriguez WE; Rosenberger D; Chen J; Sen U; Tyagi N; Moshal KS; Vacek T; Kang YJ; Tyagi SC
    Cardiovasc Toxicol; 2008; 8(3):137-44. PubMed ID: 18679830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
    Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
    Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
    Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
    Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
    Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
    Fan D; Takawale A; Shen M; Samokhvalov V; Basu R; Patel V; Wang X; Fernandez-Patron C; Seubert JM; Oudit GY; Kassiri Z
    Hypertension; 2016 Oct; 68(4):937-48. PubMed ID: 27550917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
    Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice.
    Nemska S; Gassmann M; Bang ML; Frossard N; Tavakoli R
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):792-801. PubMed ID: 34882111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.
    Qin Q; Qu C; Niu T; Zang H; Qi L; Lyu L; Wang X; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
    Hypertension; 2016 Jan; 67(1):107-17. PubMed ID: 26573705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.
    Seno A; Takeda Y; Matsui M; Okuda A; Nakano T; Nakada Y; Kumazawa T; Nakagawa H; Nishida T; Onoue K; Somekawa S; Watanabe M; Kawata H; Kawakami R; Okura H; Uemura S; Saito Y
    Hypertension; 2016 Sep; 68(3):678-87. PubMed ID: 27480835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
    Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
    Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.